About this book:

*Aging Biology and Clinical Care* provides a comprehensive overview of the geroscience framework, which shifts the medical paradigm from treating individual chronic diseases to targeting the underlying biological mechanisms of aging. The text synthesizes core "hallmarks" of aging—including genomic instability, epigenetic drift, mitochondrial dysfunction, and cellular senescence—into an integrated systems network. By framing aging as a modifiable biological process rather than an inevitability, the authors argue that clinicians can extend human healthspan and compress morbidity through proactive, evidence-based interventions.

The book transitions from molecular theory to clinical practice by evaluating a wide range of longevity-promoting strategies. It examines lifestyle foundations such as personalized nutrition, intermittent fasting, and physical activity, alongside emerging pharmacologic modulators like metformin, rapalogs, and NAD+ boosters. A significant portion of the text is dedicated to the development of senolytics and senomorphics, which aim to clear or modulate the harmful secretory phenotypes of senescent cells. Crucially, the authors advocate for sophisticated combination and sequence strategies, matching interventions to an individual’s unique biological profile.

To bridge the gap between research and the clinic, the book explores the necessity of validated biomarkers, such as epigenetic clocks and proteomic panels, to estimate biological age and monitor treatment efficacy. It addresses the challenges of "geroprotective" trial design, emphasizing the move toward composite endpoints that measure functional resilience and multi-disease prevention. The text concludes by discussing the implementation of these tools within primary care, while stressing the ethical imperative of ensuring that advances in longevity science are accessible and equitable across diverse populations.

Ultimately, the book serves as a roadmap for the future of preventive medicine. It envisions a societal shift in which healthcare infrastructure, regulatory policy, and economic models are redesigned to support a "multi-stage life." By integrating deep biological insights with practical clinical care, the authors provide a framework for a world where extending the period of life spent in high vitality is the primary goal of the medical enterprise.

What You'll Find Inside:

• The Geroscience Framework: Understanding how to target fundamental biological mechanisms of aging to delay multiple chronic diseases simultaneously.
• Hallmarks of Aging: Deep dives into cellular senescence, genomic instability, epigenetic drift, and mitochondrial dysfunction as interconnected drivers of decline.
• Diagnostic Biomarkers: Evaluation of epigenetic clocks, proteomic panels, and functional assessments to estimate biological age in clinical settings.
• Translational Interventions: Evidence-based analysis of lifestyle levers like fasting and exercise alongside pharmacologic modulators like Metformin and Rapalogs.
• Implementation and Ethics: Practical roadmaps for integrating longevity care into primary care while addressing health equity and regulatory challenges.

Who's It For:

This book is primarily intended for healthcare professionals, clinical researchers, and policymakers seeking an evidence-based bridge between laboratory aging research and preventive medicine. It is particularly valuable for primary care physicians and geriatricians who wish to incorporate geroscience principles into routine patient care. Additionally, it serves as a comprehensive resource for students and academics in the fields of biology and public health interested in the socioeconomic and ethical implications of extending human healthspan.